Applied Genetic Technologies Corporation / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €280.00K -35.0% -€61.54M +23.5% -21,976.6% -100 pp -€54.91M +29.2% -19,610.5% -97 pp
    €430.77K -79.6% -€49.82M +26.0% -11,565.8% -97 pp -€42.48M +22.0% -9,862.4% -82 pp
    €2.11M -94.1% -€39.54M +2,187.7% -1,870.9% -19 pp -€34.83M +74.6% -1,647.9% -16 pp
    €35.92M +72.4% -€1.73M -90.6% -4.8% +0.83 pp -€19.94M -27.0% -55.5% +0.76 pp
    €20.84M -38.7% -€18.35M -5,333.4% -88.1% -0.89 pp -€27.33M +5.3% -131.1% -0.55 pp
    €34.01M -16.7% €350.65K -129.5% 1.0% +0.039 pp -€25.94M -140.9% -76.3% -2.3 pp
    €40.80M +1,911.9% -€1.19M -94.3% -2.9% +10 pp €63.40M -484.0% 155.4% +9.7 pp
    €2.03M +108.5% -€20.95M +52.9% -1,033.1% +3.8 pp -€16.51M +65.9% -814.0% +2.1 pp
    €972.69K +19.9% -€13.71M +218.8% -1,409.0% -8.8 pp -€9.95M +414.3% -1,023.2% -7.8 pp
    €811.58K -12.9% -€4.30M +159.4% -529.7% -3.5 pp -€1.94M +77.7% -238.4% -1.2 pp
    €932.20K -€1.66M -177.8% -€1.09M -116.8%

    Notifications